See the article "".
Atrial septal defect (ASD) is one of the most common congenital heart disease and the percutaneous closure of ASD is a gold standard in the treatment of ASDs, which has shown excellent results. Most of the studies have shown that transcatheter closure of moderate-sized ASD is safe and effective.1) However, it has been still challenging to close large or very large ASD by transcatheter technique. In addition, it often needs special modified implantation techniques (MIT); balloon assisted technique, right or left upper pulmonary vein techniques, and so on. These MIT increased success rate of implantation.2)3)
Actually, there is no universally accepted definition for large and very large ASDs. However, usually ASDs more than 20 mm in adults have been considered as large ASD.4)5) In this study, the authors6) used more strict definition of large ASD that the defect is more than 25 mm but showed excellent outcome. It means that the size is not matter except very large ASDs (more than 40 mm) but the adjacent rim anatomy is concern.
The absolute contraindication for transcatheter closure of ASD is mitral rim deficiency because of mitral valve touching/erosion and the defect more than 40 mm. Also, the posterior-inferior rim deficiency is a relative contraindication because of embolization risk. Amedro et al.7) reported 44.4% of success rate of transcatheter closure of ASD in inferior-posterior rim deficiency. Recently, Chen et al.8) reported the initial experiences of transcatheter closure of very large secundum ASD (36–42 mm) using domestic septal occluder (44–48 mm) with good result but no long-term outcome. In addition, severe pulmonary hypertension or Eisenmenger syndrome are contraindicated. Of course, the fenestrated device may be considered in this situation after vasoreactivity test.
The aortic rim deficiency is not a contraindication of transcatheter closure, but it has reported that aortic rim deficiency is related with erosion risk. Therefore, the accurate imaging acquisition of ASD is very important. For this reason, real-time 3-dimensional transesophageal echocardiography guided procedure has performed at many centers and it has showed good results recently.
Intracardiac echocardiography (ICE)-guided procedure has increased and showed safe and effective immediate result in adults and pediatric patients.9)10) ICE provides excellent imaging of the anatomy of ASD and adjacent structures, and especially posterior and inferior rim are well visualized. In addition, ICE can decrease the needs for endotracheal intubation and general anesthesia during the procedure. In this point, the authors6) of this study showed excellent early and long-term outcome of ICE-guided closure of ASD. However, this technique requires the interventionist to have enough experiences and capability to interpret the ICE images. In this study, only 1 expert performed all procedures and made excellent results.
Although this study did not describe the change of exercise capacity and left ventricular function after transcatheter closure of ASD, they already reported increased exercise capacity and ventricular function in previous report.11)
Finally, this report showed the excellent early and long-term outcomes of ICE-guided transcatheter closure of large and very large ASD using MITs. The accurate anatomy and size evaluation before procedure is very important. Meticulous evaluation including age-related comorbidity, arrhythmia, pulmonary hypertension and ventricular function before and after procedure make to ensure excellent outcomes.
References
1. Kazmouz S, Kenny D, Cao QL, Kavinsky CJ, Hijazi ZM. Transcatheter closure of secundum atrial septal defects. J Invasive Cardiol. 2013; 25:257–264.
2. Ananthakrishna Pillai A, Upadhyay A, Gousy S, Handa A. Impact of modified techniques of transcatheter closure in large atrial septal defects (≥30 mm) with anatomic complexities. Cardiol Young. 2018; 28:1122–1133.
3. Narin N, Baykan A, Argun M, et al. New modified balloon-assisted technique to provide appropriate deployment in the closure of large secundum atrial septal defect using amplatzer septal occluder in children. J Invasive Cardiol. 2014; 26:597–602.
4. Varma C, Benson LN, Silversides C, et al. Outcomes and alternative techniques for device closure of the large secundum atrial septal defect. Catheter Cardiovasc Interv. 2004; 61:131–139.
5. Berger F, Ewert P, Abdul-Khaliq H, Nürnberg JH, Lange PE. Percutaneous closure of large atrial septal defects with the Amplatzer Septal Occluder: technical overkill or recommendable alternative treatment? J Interv Cardiol. 2001; 14:63–67.
6. Jung SY, Kim AY, Jung JW, Choi JY. Procedural, early and long-term outcomes after percutaneous closure of atrial septal defect: comparison between large and very large atrial septal defect groups. Korean Circ J. 2019; 49:975–986.
7. Amedro P, Bayburt S, Assaidi A, et al. Should transcatheter closure of atrial septal defects with inferior-posterior deficient rim still be attempted? J Thorac Dis. 2019; 11:708–716.
8. Chen Q, Cao H, Zhang GC, Chen LW, Xu F, Zhang JX. Midterm follow-up of transthoracic device closure of an atrial septal defect using the very large domestic occluder (44–48 mm), a single Chinese cardiac center experience. J Cardiothorac Surg. 2017; 12:74.
9. Medford BA, Taggart NW, Cabalka AK, et al. Intracardiac echocardiography during atrial septal defect and patent foramen ovale device closure in pediatric and adolescent patients. J Am Soc Echocardiogr. 2014; 27:984–990.